162 related articles for article (PubMed ID: 24245934)
1. Magnetic resonance imaging identifies early effects of sunitinib treatment in human melanoma xenografts.
Gaustad JV; Pozdniakova V; Hompland T; Simonsen TG; Rofstad EK
J Exp Clin Cancer Res; 2013 Nov; 32(1):93. PubMed ID: 24245934
[TBL] [Abstract][Full Text] [Related]
2. Early effects of low dose bevacizumab treatment assessed by magnetic resonance imaging.
Gaustad JV; Simonsen TG; Smistad R; Wegner CS; Andersen LM; Rofstad EK
BMC Cancer; 2015 Nov; 15():900. PubMed ID: 26573613
[TBL] [Abstract][Full Text] [Related]
3. DCE-MRI of Sunitinib-Induced Changes in Tumor Microvasculature and Hypoxia: A Study of Pancreatic Ductal Adenocarcinoma Xenografts.
Wegner CS; Hauge A; Simonsen TG; Gaustad JV; Andersen LMK; Rofstad EK
Neoplasia; 2018 Jul; 20(7):734-744. PubMed ID: 29886124
[TBL] [Abstract][Full Text] [Related]
4. Dynamic contrast-enhanced magnetic resonance imaging of vascular changes induced by sunitinib in papillary renal cell carcinoma xenograft tumors.
Hillman GG; Singh-Gupta V; Zhang H; Al-Bashir AK; Katkuri Y; Li M; Yunker CK; Patel AD; Abrams J; Haacke EM
Neoplasia; 2009 Sep; 11(9):910-20. PubMed ID: 19724685
[TBL] [Abstract][Full Text] [Related]
5. DW-MRI in assessment of the hypoxic fraction, interstitial fluid pressure, and metastatic propensity of melanoma xenografts.
Hompland T; Ellingsen C; Galappathi K; Rofstad EK
BMC Cancer; 2014 Feb; 14():92. PubMed ID: 24528854
[TBL] [Abstract][Full Text] [Related]
6. Sunitinib treatment does not improve blood supply but induces hypoxia in human melanoma xenografts.
Gaustad JV; Simonsen TG; Leinaas MN; Rofstad EK
BMC Cancer; 2012 Sep; 12():388. PubMed ID: 22947392
[TBL] [Abstract][Full Text] [Related]
7. Connective tissue of cervical carcinoma xenografts: associations with tumor hypoxia and interstitial fluid pressure and its assessment by DCE-MRI and DW-MRI.
Hompland T; Ellingsen C; Galappathi K; Rofstad EK
Acta Oncol; 2014 Jan; 53(1):6-15. PubMed ID: 23445339
[TBL] [Abstract][Full Text] [Related]
8. Assessment of tumor radioresponsiveness and metastatic potential by dynamic contrast-enhanced magnetic resonance imaging.
Øvrebø KM; Gulliksrud K; Mathiesen B; Rofstad EK
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):255-61. PubMed ID: 21816291
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the interstitial fluid pressure of tumors by dynamic contrast-enhanced magnetic resonance imaging with contrast agents of different molecular weights.
Hompland T; Gulliksrud K; Ellingsen C; Rofstad EK
Acta Oncol; 2013 Apr; 52(3):627-35. PubMed ID: 23126523
[TBL] [Abstract][Full Text] [Related]
10. DCE-MRI of patient-derived xenograft models of uterine cervix carcinoma: associations with parameters of the tumor microenvironment.
Hauge A; Wegner CS; Gaustad JV; Simonsen TG; Andersen LMK; Rofstad EK
J Transl Med; 2017 Nov; 15(1):225. PubMed ID: 29100521
[TBL] [Abstract][Full Text] [Related]
11. Assessment of tumor hypoxia and interstitial fluid pressure by gadomelitol-based dynamic contrast-enhanced magnetic resonance imaging.
Gulliksrud K; Hompland T; Galappathi K; Rofstad EK
Radiother Oncol; 2011 Oct; 101(1):217-22. PubMed ID: 21840612
[TBL] [Abstract][Full Text] [Related]
12. Antiangiogenic agents targeting different angiogenic pathways have opposite effects on tumor hypoxia in R-18 human melanoma xenografts.
Gaustad JV; Simonsen TG; Andersen LMK; Rofstad EK
BMC Cancer; 2017 Jun; 17(1):411. PubMed ID: 28606060
[TBL] [Abstract][Full Text] [Related]
13. Dynamic contrast-enhanced MRI of the microenvironment of pancreatic adenocarcinoma xenografts.
Wegner CS; Hauge A; Gaustad JV; Andersen LMK; Simonsen TG; Galappathi K; Rofstad EK
Acta Oncol; 2017 Dec; 56(12):1754-1762. PubMed ID: 28661213
[TBL] [Abstract][Full Text] [Related]
14. In vivo imaging of tumor physiological, metabolic, and redox changes in response to the anti-angiogenic agent sunitinib: longitudinal assessment to identify transient vascular renormalization.
Matsumoto S; Saito K; Takakusagi Y; Matsuo M; Munasinghe JP; Morris HD; Lizak MJ; Merkle H; Yasukawa K; Devasahayam N; Suburamanian S; Mitchell JB; Krishna MC
Antioxid Redox Signal; 2014 Sep; 21(8):1145-55. PubMed ID: 24597714
[TBL] [Abstract][Full Text] [Related]
15. Dynamic contrast-enhanced magnetic resonance imaging of the metastatic potential of melanoma xenografts.
Ovrebø KM; Ellingsen C; Galappathi K; Rofstad EK
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e121-7. PubMed ID: 22381901
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance imaging of tumor necrosis.
Egeland TA; Gaustad JV; Galappathi K; Rofstad EK
Acta Oncol; 2011 Apr; 50(3):427-34. PubMed ID: 20950229
[TBL] [Abstract][Full Text] [Related]
17. Dynamic contrast-enhanced magnetic resonance imaging of tumor interstitial fluid pressure.
Gulliksrud K; Brurberg KG; Rofstad EK
Radiother Oncol; 2009 Apr; 91(1):107-13. PubMed ID: 18973959
[TBL] [Abstract][Full Text] [Related]
18. DCE-MRI of the hypoxic fraction, radioresponsiveness, and metastatic propensity of cervical carcinoma xenografts.
Ellingsen C; Hompland T; Galappathi K; Mathiesen B; Rofstad EK
Radiother Oncol; 2014 Feb; 110(2):335-41. PubMed ID: 24231244
[TBL] [Abstract][Full Text] [Related]
19. Preclinical evaluation of Gd-DTPA and gadomelitol as contrast agents in DCE-MRI of cervical carcinoma interstitial fluid pressure.
Hompland T; Ellingsen C; Rofstad EK
BMC Cancer; 2012 Nov; 12():544. PubMed ID: 23173554
[TBL] [Abstract][Full Text] [Related]
20. DCE-MRI and Quantitative Histology Reveal Enhanced Vessel Maturation but Impaired Perfusion and Increased Hypoxia in Bevacizumab-Treated Cervical Carcinoma.
Hauge A; Gaustad JV; Huang R; Simonsen TG; Wegner CS; Andersen LMK; Rofstad EK
Int J Radiat Oncol Biol Phys; 2019 Jul; 104(3):666-676. PubMed ID: 30858145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
